Onco-Nephrology Core Curriculum (2023): Navigating the Evolving Landscape of Cancer Therapies and Kidney Injury

The rapidly evolving landscape of cancer therapies has brought about significant improvements in patient survival rates. However, this progress has also introduced new challenges for nephrologists. The innovative cancer treatments have been found to be directly nephrotoxic, leading to unique pathogenic mechanisms and patterns of renal injury.

In response to these emerging challenges, the ASN Onco-Nephrology curriculum has been updated to address these novel clinical entities. This comprehensive curriculum provides clinicians with essential information on innovations in laboratory and diagnostic techniques, as well as new management strategies that have recently developed.

The Impact of Cancer Therapies on Kidney Health

The recent proliferation of new cancer therapies has led to an increase in cancer treatment-related kidney injury. Nephrologists must now navigate this complex landscape to effectively evaluate and manage patients. The updated curriculum aims to equip clinicians with the knowledge and skills necessary to tackle these new challenges.

Staying Ahead of the Curve: Innovations in Laboratory and Diagnostic Techniques

The Onco-Nephrology curriculum covers the latest advancements in laboratory and diagnostic techniques, enabling clinicians to stay ahead of the curve in the diagnosis and management of cancer treatment-related kidney injury.

By addressing the unique challenges posed by innovative cancer therapies, this updated curriculum provides a vital resource for clinicians seeking to improve patient outcomes in the face of rapidly evolving cancer treatments.